MedTrace Logo

Patient-derived Organoid Model and Circulating Tumor Cells for Treatment Response of Lung Cancer

NCT03655015 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2026-04-20

No results posted yet for this study

Summary

Create a living biobank of PDOs from Stage I-III lung cancer patients.

Conditions

  • Lung Neoplasm

Interventions

PROCEDURE

Lung Tumor Resection

Lung Tumor Resection

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • The University of Texas Health Science Center at San Antonio

    lead OTHER

Principal Investigators

  • Josephine Taverna, MD · UT Health San Antonio M.D. Anderson Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-16
Primary Completion
2028-12-01
Completion
2029-12-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03655015 on ClinicalTrials.gov